Cognoa

company

About

Cognoa is a behavioral health company.

Details

Last Funding Type
Series B
Last Funding Money Raised
$73.10M
Industries
Biotechnology,Health Care,Health Diagnostics,Therapeutics
Founded date
Jan 1, 2013
Number Of Employee
51 - 100
Operating Status
Active
Legal Name
Cognoa, Inc.

Cognoa is a pediatric behavioral health company developing digital diagnostics and therapeutics to enable the earlier diagnosis and treatment of behavioral health conditions, such as autism. Its ai technology platform will enable the product pipeline to address additional unmet needs including adhd and anxiety. It is focused on improving the lives and outcomes of children and families living with behavioral conditions.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
5
$127M
Cognoa has raised a total of $127M in funding over 2 rounds. Their latest funding was raised on Nov 14, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 14, 2022 Series B $73.10M Detail
Oct 31, 2019 Series A 1 Detail
Oct 27, 2019 Series A $45.07M 1 Morningside Venture Investments Detail
Oct 31, 2016 Series A $3.82M 1 Morningside Group Detail
Aug 28, 2013 Series A $5M 1 Morningside Group Detail

Investors

Number of Lead Investors
Number of Investors
3
3
Cognoa is funded by 3 investors. Morningside Venture Investments and Morningside Group are the most recent investors.
Investor Name Lead Investor Funding Round
Morningside Venture Investments Yes Series A
Morningside Group Yes Series A
Stanford Technology Ventures Program Series A

Employee Profiles

Number of Employee Profiles
6
Cognoa has 6 current employee profiles, including Executive Halim Abbas
Executive
Executive
Board member
Executive